Cargando…

BRET-Based Self-Cleaving Biosensors for SARS-CoV-2 3CLpro Inhibitor Discovery

The 3C-like protease (3CLpro) of SARS-CoV-2 is an attractive drug target for developing antivirals against SARS-CoV-2. A few small molecule inhibitors of 3CLpro are in clinical trials for COVID-19 treatments, and more inhibitors are under development. One limiting factor for 3CLpro inhibitors develo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Ningke, Peng, Chen, Zhang, Lijing, Zhu, Yuyao, Hu, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430692/ https://www.ncbi.nlm.nih.gov/pubmed/35758897 http://dx.doi.org/10.1128/spectrum.02559-21

Ejemplares similares

Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro
por: Hou, Ningke, et al.
Publicado: (2023)

Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease
por: Kuang, Yi, et al.
Publicado: (2023)

Progress on SARS-CoV-2 3CLpro Inhibitors: Inspiration from SARS-CoV 3CLpro Peptidomimetics and Small-Molecule Anti-Inflammatory Compounds
por: Zhu, Jiajie, et al.
Publicado: (2022)

Developments in FRET- and BRET-Based Biosensors
por: Wu, Yuexin, et al.
Publicado: (2022)

BRET Biosensor Analysis of Receptor Tyrosine Kinase Functionality
por: Siddiqui, Sana, et al.
Publicado: (2013)

An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro
por: Liao, Qi, et al.
Publicado: (2021)

Multistep rational molecular design and combined docking for discovery of novel classes of inhibitors of SARS-CoV-2 main protease 3CLpro
por: Tumskiy, Roman S., et al.
Publicado: (2021)

Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors
por: Ghosh, Arun K., et al.
Publicado: (2007)

Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening
por: Abian, Olga, et al.
Publicado: (2020)

Detecting SARS-CoV-2 3CLpro expression and activity using a polyclonal antiserum and a luciferase-based biosensor
por: O'Brien, Amornrat, et al.
Publicado: (2021)

BRET biosensors to study GPCR biology, pharmacology, and signal transduction
por: Salahpour, Ali, et al.
Publicado: (2012)

Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro
por: Jo, Seri, et al.
Publicado: (2020)

Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitors
por: Paul, Abhik, et al.
Publicado: (2021)

A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors
por: Jo, Seri, et al.
Publicado: (2022)

Reconstruction of the unbinding pathways of noncovalent SARS-CoV and SARS-CoV-2 3CLpro inhibitors using unbiased molecular dynamics simulations
por: Noroozi Tiyoula, Fereshteh, et al.
Publicado: (2022)

Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro
por: Hameedi, Mikhail Ali, et al.
Publicado: (2021)

Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds
por: Rizzuti, Bruno, et al.
Publicado: (2021)

Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro
por: Hameedi, Mikhail A., et al.
Publicado: (2022)

Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
por: Mody, Vicky, et al.
Publicado: (2021)

Label-free duplex SAMDI-MS screen reveals novel SARS-CoV-2 3CLpro inhibitors
por: Scholle, Michael D., et al.
Publicado: (2022)

A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors
por: Vankadara, Subramanyam, et al.
Publicado: (2021)

SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species
por: Moustaqil, Mehdi, et al.
Publicado: (2021)

Evolution of BRET Biosensors from Live Cell to Tissue-Scale In vivo Imaging
por: De, Abhijit, et al.
Publicado: (2013)

Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations
por: Grottesi, Alessandro, et al.
Publicado: (2020)

Development of a colorimetric assay for the detection of SARS-CoV-2 3CLpro activity
por: Garland, Gavin D., et al.
Publicado: (2022)

Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors
por: Ghosh, Arun K., et al.
Publicado: (2008)

3CLpro inhibitors: DEL-based molecular generation
por: Xiong, Feng, et al.
Publicado: (2022)

Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus
por: Hartini, Yustina, et al.
Publicado: (2021)

Repositioning therapeutics for COVID-19: virtual screening of the potent synthetic and natural compounds as SARS-CoV-2 3CLpro inhibitors
por: Sattari, Ahmad, et al.
Publicado: (2021)

Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro
por: Silva, Rai C., et al.
Publicado: (2021)

BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
por: Bery, Nicolas, et al.
Publicado: (2018)

A platform of BRET-FRET hybrid biosensors for optogenetics, chemical screening, and in vivo imaging
por: Komatsu, Naoki, et al.
Publicado: (2018)

Experimental determination of the bioluminescence resonance energy transfer (BRET) Förster distances of NanoBRET and red-shifted BRET pairs
por: Weihs, Felix, et al.
Publicado: (2020)

Oxidative stress transforms 3CLpro into an insoluble and more active form to promote SARS-CoV-2 replication
por: Du, Liubing, et al.
Publicado: (2021)

Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs
por: Rizzuti, Bruno, et al.
Publicado: (2021)

Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach
por: Gupta, Yash, et al.
Publicado: (2021)

Virtual screening and molecular dynamics simulation analysis of Forsythoside A as a plant-derived inhibitor of SARS-CoV-2 3CLpro
por: Bibi, Shabana, et al.
Publicado: (2022)

A genetically encoded BRET-based SARS-CoV-2 main protease activity sensor
por: Geethakumari, Anupriya M., et al.
Publicado: (2023)

Correction: BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
por: Bery, Nicolas, et al.
Publicado: (2018)

SARS-CoV-2 3CLpro whole human proteome cleavage prediction and enrichment/depletion analysis
por: Prescott, Lucas
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ntbsr1vvsho2b34vgkvj27np1g